Artfix Ltd. is a medical device company focused on the field of electrophysiology.

ArtFix aims to deliver a true breakthrough in the atrial fibrillation (AF) market with its innovative one-shot cryoablation catheter.

The key advantages of the ArtFix system include:

• Safety: A controlled cryoablation system minimizes complication rates compared to other ablation methods.
• Efficacy: The cooling tip is designed to create a continuous line with full tissue contact, enabling effective transmural ablations.
• Usability: Offers a genuine “one-shot” procedure, eliminating the need for a 3D mapping system.

The ArtFix system supports both box and linear lesions, making it suitable for treating paroxysmal and persistent AF patients.